Full Text
PSS14 COST-EFFECTIVENESS OF THE TREATMENT FOR MODERATE TO SEVERE PSORIASIS IN MEXICO- INFLIXIMAB, ETANERCEPT AND EFALIZUMAB

Abstract

Authors

E Mucio R Rivas L Zapata

Back to Volume 11, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×